Epalrestat 150 mg |EPSTATE SR 150

 

Epalrestat 150 mg is a prescription medicine used in the management of certain diabetic nerve-related complications under medical supervision. EPSTATE SR 150 is a branded formulation containing Epalrestat 150 mg as the active ingredient and is marketed by Steris Healthcare Pvt Ltd.

Epalrestat belongs to a class of medicines known as aldose reductase inhibitors, which are prescribed for diabetic peripheral neuropathy management. It works by helping reduce the activity of aldose reductase, an enzyme associated with the polyol pathway that may contribute to nerve-related complications in people with diabetes.

EPSTATE SR 150 is formulated as an enteric-coated delayed-release tablet and is available in a strip of 10 tablets. The product is manufactured and marketed under WHO-GMP certified quality standards. As a prescription-only medicine, Epalrestat 150 mg should be used only after consultation with a qualified healthcare professional.

What is Epalrestat 150 mg?

Epalrestat 150 mg is a prescription medicine commonly prescribed for diabetic peripheral neuropathy, a condition where prolonged high blood sugar levels may affect nerves and cause symptoms such as numbness, tingling, burning sensations, or discomfort in the hands and feet.

The active ingredient, Epalrestat, works by inhibiting aldose reductase, an enzyme involved in glucose metabolism pathways. By controlling this pathway, Epalrestat may help support nerve health and reduce the progression of certain diabetic nerve complications when prescribed appropriately.

EPSTATE SR 150 should be taken according to the dosage and duration recommended by the treating physician.

Uses of Epalrestat 150 mg Tablets

Doctors may prescribe Epalrestat 150 mg Tablets for:

• Management of diabetic peripheral neuropathy
• Supporting treatment of diabetes-related nerve complications
• Reducing symptoms associated with diabetic nerve damage, such as tingling, numbness, or burning sensations

The suitability of Epalrestat depends on individual patient factors, including diabetes control, medical history, and existing health conditions.

Patients should not start Epalrestat therapy without medical advice.

How Does Epalrestat 150 mg Tablets Work?

Epalrestat works by inhibiting the enzyme aldose reductase, which plays a role in converting glucose into sorbitol through the polyol pathway.

In diabetes, increased glucose levels may lead to excessive sorbitol accumulation in nerve tissues, which can contribute to nerve-related complications. By reducing aldose reductase activity, Epalrestat may help protect nerve function and manage symptoms associated with diabetic neuropathy.

The enteric-coated delayed-release formulation is designed to provide controlled release characteristics. The tablet should be taken exactly as instructed by the healthcare provider.

Benefits of Epalrestat 150 mg Tablets

When prescribed for appropriate patients, Epalrestat 150 mg may provide supportive benefits in diabetic neuropathy management.

Possible benefits include:

• Helps manage symptoms associated with diabetic nerve complications
• Supports nerve health in diabetic patients
• Helps reduce progression of certain diabetes-related nerve changes
• Provides a targeted therapeutic approach through aldose reductase inhibition

Individual response to treatment may vary. Maintaining proper blood glucose control along with prescribed therapy is important for overall diabetes management.

Dosage and Administration of Epalrestat 150 mg

The dosage of EPSTATE SR 150 should be determined by a doctor based on the patient’s condition.

General precautions:

• Take the medicine only as prescribed.
• Do not change the dose without medical guidance.
• Swallow the tablet whole with water.
• Avoid crushing or chewing the tablet unless advised by a healthcare professional.
• Continue treatment for the duration recommended by your doctor.

Missing doses or discontinuing treatment without consultation may affect treatment outcomes.

Safety Information and Precautions

Before using Epalrestat 150 mg Tablets, inform your doctor if you have:

• Liver-related problems
• Kidney-related conditions
• Allergies to medicines
• Other ongoing treatments
• Pregnancy or breastfeeding considerations

Your doctor may evaluate your health condition before prescribing Epalrestat.

Avoid self-medication, especially when managing diabetes-related complications, as proper diagnosis and monitoring are required.

Possible Side Effects of Epalrestat 150 mg

Like other prescription medicines, Epalrestat may cause side effects in some individuals.

Possible side effects may include:

• Nausea
• Stomach discomfort
• Loss of appetite
• Diarrhea
• Abdominal discomfort
• Liver enzyme changes

If any side effect becomes persistent or severe, consult your healthcare provider immediately.

Why Choose Epalrestat 150 mg Tablets by Steris Healthcare Pvt Ltd?

EPSTATE SR 150 is a branded Epalrestat 150 mg formulation marketed by Steris Healthcare Pvt Ltd.

Key product features include:

• Contains Epalrestat 150 mg
• Enteric-coated delayed-release tablet formulation
• Available in a strip of 10 tablets
• Prescription-based diabetic neuropathy medicine
• Manufactured under WHO-GMP certified quality standards

Steris Healthcare Pvt Ltd focuses on delivering pharmaceutical formulations developed according to regulated quality practices.

Frequently Asked Questions 

1. What is Epalrestat 150 mg used for?

Epalrestat 150 mg is prescribed for the management of diabetic peripheral neuropathy and related nerve complications associated with diabetes. It should be used only under a doctor’s supervision.

2. What is Epalrestat 150 mg Tablets?

EPSTATE SR 150 is a branded prescription medicine containing Epalrestat 150 mg. It is marketed by Steris Healthcare Pvt Ltd and available as an enteric-coated delayed-release tablet.

3. How does Epalrestat 150 mg work?

Epalrestat works by inhibiting aldose reductase, an enzyme involved in the polyol pathway. This action may help manage diabetes-related nerve complications.

4. Can I take Epalrestat 150 mg without a prescription?

No. Epalrestat 150 mg is a prescription-only medicine and should be taken only after consultation with a registered medical practitioner.

5. What is the composition of Epalrestat 150 mg Tablets?

EPSTATE SR 150 contains Epalrestat 150 mg as its active pharmaceutical ingredient.

6. What is the pack size of Epalrestat 150 mg tablets?

EPSTATE SR 150 is supplied in a strip containing 10 tablets.

7. Who manufactures Epalrestat 150 mg Tablets?

EPSTATE SR 150 is marketed by Steris Healthcare Pvt Ltd.

8. Is Epalrestat helpful for diabetic nerve problems?

Epalrestat is prescribed for diabetic peripheral neuropathy management. The doctor decides its suitability based on the patient’s symptoms and medical condition.

9. How should Epalrestat 150 mg Tablets tablets be taken?

Take EPSTATE SR 150 exactly as prescribed. The tablet should generally be swallowed whole with water and should not be modified without medical advice.

10. Is Epalrestat 150 mg Tablets available without a prescription?

No. EPSTATE SR 150 requires a valid prescription from a qualified healthcare professional.

Conclusion

Epalrestat 150 mg (EPSTATE SR 150) by Steris Healthcare Pvt Ltd is a prescription medicine formulated for the management of diabetic peripheral neuropathy and related nerve complications. With an enteric-coated delayed-release tablet formulation and WHO-GMP certified manufacturing standards, EPSTATE SR 150 provides a regulated pharmaceutical option for patients requiring Epalrestat therapy.

Product Information 

Brand Name: EPSTATE SR 150
Composition: Epalrestat 150 mg
Manufacturer/Marketed By: Steris Healthcare Pvt Ltd
Dosage Form: Enteric-coated delayed-release tablet
Pack Size: Strip of 10 tablets
Therapeutic Category: Antidiabetic neuropathy management medicine
Regulatory Standard: WHO-GMP certified manufacturing standards
Schedule: Prescription only (Valid prescription required)